Potiga



Indications and Reactions:

Role Indications Reactions
Primary
Epilepsy 36.2%
Convulsion 22.6%
Partial Seizures 18.3%
Product Used For Unknown Indication 14.5%
Post-traumatic Epilepsy 2.3%
Partial Seizures With Secondary Generalisation 1.7%
Lennox-gastaut Syndrome 1.4%
Back Pain 0.6%
Migraine 0.6%
Arrhythmia 0.3%
Complex Partial Seizures 0.3%
Depression 0.3%
Seizure Cluster 0.3%
Seizures 0.3%
Temporal Lobe Epilepsy 0.3%
Urinary Retention 34.4%
Convulsion 11.9%
Chromaturia 6.6%
Epilepsy 6.6%
Skin Discolouration 3.3%
Somnolence 3.3%
Urinary Hesitation 3.3%
Aggression 2.6%
Diarrhoea 2.6%
Fatigue 2.6%
Psychotic Disorder 2.6%
Rash 2.6%
Sudden Unexplained Death In Epilepsy 2.6%
Urinary Tract Infection 2.6%
Completed Suicide 2.0%
Condition Aggravated 2.0%
Drug Ineffective 2.0%
Irritability 2.0%
Speech Disorder 2.0%
Urinary Tract Disorder 2.0%
Secondary
Epilepsy 59.4%
Partial Seizures 25.0%
Convulsion 9.4%
Petit Mal Epilepsy 3.1%
Seasonal Allergy 3.1%
Mental Impairment 20.0%
Syncope 20.0%
Somnolence 10.0%
Toxicity To Various Agents 10.0%
Urinary Tract Infection 10.0%
Urticaria 10.0%
Vitreous Floaters 10.0%
Weight Increased 10.0%
Concomitant
Product Used For Unknown Indication 32.7%
Convulsion 15.3%
Epilepsy 10.7%
Complex Partial Seizures 10.0%
Headache 7.3%
Insomnia 7.3%
Pharyngitis Streptococcal 7.3%
Vitamin Supplementation 7.3%
Grand Mal Convulsion 0.7%
Temporal Lobe Epilepsy 0.7%
Urinary Incontinence 0.7%
Postictal State 52.4%
Cataract 4.8%
Convulsion 4.8%
Drug Dose Omission 4.8%
Muscle Spasms 4.8%
Retinopathy 4.8%
Sudden Unexplained Death In Epilepsy 4.8%
Urinary Tract Infection 4.8%
Vagal Nerve Stimulator Implantation 4.8%
Visual Field Defect 4.8%
Weight Increased 4.8%